Asunto(s)
Infecciones por Coronavirus/epidemiología , Coronavirus , Brotes de Enfermedades/prevención & control , Pandemias , Neumonía Viral/epidemiología , Vigilancia en Salud Pública/métodos , Betacoronavirus , COVID-19 , Prueba de COVID-19 , Técnicas de Laboratorio Clínico , Trazado de Contacto , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/tratamiento farmacológico , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/terapia , Epidemiología , Humanos , Pandemias/prevención & control , Neumonía Viral/diagnóstico , Neumonía Viral/prevención & control , Neumonía Viral/terapia , Cuarentena , SARS-CoV-2 , Tratamiento Farmacológico de COVID-19RESUMEN
Mentors rarely receive education about the unique needs of underrepresented scholars in the biomedical and behavioral sciences. We hypothesized that mentor-training and peer-mentoring interventions for these scholars would enrich the perceived quality and breadth of discussions between mentor-protégé dyads (i.e., mentor-protégé pairs). Our multicenter, randomized study of 150 underrepresented scholar-mentor dyads compared: 1) mentor training, 2) protégé peer mentoring, 3) combined mentor training and peer mentoring, and 4) a control condition (i.e., usual practice of mentoring). In this secondary analysis, the outcome variables were quality of dyad time and breadth of their discussions. Protégé participants were graduate students, fellows, and junior faculty in behavioral and biomedical research and healthcare. Dyads with mentor training were more likely than those without mentor training to have discussed teaching and work-life balance. Dyads with peer mentoring were more likely than those without peer mentoring to have discussed clinical care and career plans. The combined intervention dyads were more likely than controls to perceive that the quality of their time together was good/excellent. Our study supports the value of these mentoring interventions to enhance the breadth of dyad discussions and quality of time together, both important components of a good mentoring relationship.
Asunto(s)
Ciencias de la Conducta , Investigación Biomédica , Tutoría/métodos , Tutoría/normas , Mentores , Grupo Paritario , Estudiantes/psicología , Humanos , Grupos Minoritarios , Satisfacción PersonalAsunto(s)
Anemia de Células Falciformes , Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/tratamiento farmacológico , Anemia de Células Falciformes/genética , Biomarcadores/sangre , Hemoglobina Fetal/metabolismo , Hemoglobina Falciforme/genética , Hemoglobina Falciforme/metabolismo , Humanos , Hidroxiurea/uso terapéutico , Polimorfismo de Nucleótido Simple , Índice de Severidad de la EnfermedadRESUMEN
In this review, we provide a description of those candidate biomarkers which have been demonstrated by multiple-omics approaches to vary in correlation with specific clinical manifestations of sickle cell severity. We believe that future clinical analyses of severity phenotype will require a multiomic analysis, or an omics stack approach, which includes integrated interactomics. It will also require the analysis of big data sets. These candidate biomarkers, whether they are individual or panels of functionally linked markers, will require future validation in large prospective and retrospective clinical studies. Once validated, the hope is that informative biomarkers will be used for the identification of individuals most likely to experience severe complications, and thereby be applied for the design of patient-specific therapeutic approaches and response to treatment. This would be the beginning of precision medicine for sickle cell disease.
Asunto(s)
Anemia de Células Falciformes/diagnóstico , Medicina de Precisión/métodos , Anemia de Células Falciformes/genética , Biomarcadores/sangre , Hemoglobina Fetal/análisis , Perfilación de la Expresión Génica , Marcadores Genéticos , Humanos , Metabolómica , MicroARNs/genética , Proteómica , Índice de Severidad de la EnfermedadRESUMEN
PURPOSE: To conduct a randomized controlled trial to evaluate the effects of different mentoring interventions on the basic psychological need satisfaction of underrepresented minorities and women in academia. METHOD: Participants were 150 mentor/protégé dyads from three academic medical centers and eight other colleges and universities in western and central New York, randomized from 2010 to 2013 into mentor training (using principles of self-determination theory); peer mentoring for protégés; mentor training and peer mentoring for protégés combined; or control/usual practice. Protégé participants were graduate students, fellows, and junior faculty who were from underrepresented groups based on race, ethnicity, gender, or disability.The primary analysis was a comparison of intervention effects on changes in protégés' satisfaction of their basic psychological needs (competence, autonomy, and relatedness) with their mentor. They completed a well-validated, online questionnaire every two months for one year. RESULTS: There was no significant effect at the end of one year of either mentor training or peer mentoring on protégés' psychological basic need satisfaction with mentor specifically or at work in general. Exploratory analyses showed a significant effect of the mentor-based intervention on the protégés' overall psychological need satisfaction with their mentor at two months, the time point closest to completing mentor training. CONCLUSIONS: This randomized controlled trial showed a potential short-term effect of mentor training on changing basic psychological need satisfaction of underrepresented scholars with their mentors. Despite the lack of sustained effect of either mentor training or peer mentoring, these short-term changes suggest feasibility and potential for future study.
Asunto(s)
Educación de Postgrado en Medicina/métodos , Etnicidad/educación , Docentes Médicos/psicología , Tutoría/métodos , Grupos Minoritarios/educación , Médicos Mujeres/psicología , Estudiantes de Medicina/psicología , Etnicidad/psicología , Femenino , Humanos , Grupos Minoritarios/psicología , New York , Grupo Paritario , Satisfacción PersonalRESUMEN
In this minireview, we cover the discovery of the human erythrocyte α spectrin E2/E3 ubiquitin conjugating/ligating enzymatic activity and the specific cysteines involved. We then discuss the consequences when this activity is partially inhibited in sickle cell disease and the possibility that the same attenuation is occurring in multiple organ dysfunction syndrome. We finish by discussing the reasons for believing that nonerythroid α spectrin isoforms (I and II) also have this activity and the importance of testing this hypothesis. If correct, this would suggest that the nonerythroid spectrin isoforms play a major role in protein ubiquitination in all cell types. This would open new fields in experimental biology focused on uncovering the impact that this enzymatic activity has upon protein-protein interactions, protein turnover, cellular signaling, and many other functions impacted by spectrin, including DNA repair.
Asunto(s)
Anemia de Células Falciformes/enzimología , Reparación del ADN , Eritrocitos/enzimología , Insuficiencia Multiorgánica/enzimología , Transducción de Señal , Espectrina/metabolismo , Ubiquitina-Proteína Ligasas/metabolismo , Ubiquitinación , Animales , HumanosRESUMEN
Zfra is a 31-amino-acid zinc finger-like protein, which participates in the tumor necrosis factor signaling. Here, we determined that when nude mice and BALB/c mice were pre-injected with nanogram levels of a synthetic Zfra1-31 or truncated Zfra4-10 peptide via tail veins, these mice became resistant to the growth, metastasis and stemness of melanoma cells, and many malignant cancer cells. The synthetic peptides underwent self-polymerization in phosphate-buffered saline. Alteration of the Ser8 phosphorylation site to Gly8 abolished Zfra aggregation and its-mediated cancer suppression in vivo. Injected Zfra peptide autofluoresced due to polymerization and was trapped mainly in the spleen. Transfer of Zfra-stimulated spleen cells to naïve mice conferred resistance to cancer growth. Zfra-binding cells, designated Hyal-2+ CD3- CD19- Z cells, are approximately 25-30% in the normal spleen, but are significantly downregulated (near 0-3%) in tumor-growing mice. Zfra prevented the loss of Z cells caused by tumors. In vitro stimulation or education of naïve spleen cells with Zfra allowed generation of activated Z cells to confer a memory anticancer response in naïve or cancer-growing mice. In particular, Z cells are abundant in nude and NOD-SCID mice, and can be readily activated by Zfra to mount against cancer growth.
Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/farmacología , Antígenos CD19/inmunología , Complejo CD3/inmunología , Moléculas de Adhesión Celular/inmunología , Hialuronoglucosaminidasa/inmunología , Neoplasias/tratamiento farmacológico , Neoplasias/inmunología , Bazo/efectos de los fármacos , Bazo/inmunología , Secuencia de Aminoácidos , Animales , Moléculas de Adhesión Celular/genética , Proteínas Ligadas a GPI/genética , Proteínas Ligadas a GPI/inmunología , Humanos , Hialuronoglucosaminidasa/genética , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos NOD , Ratones Desnudos , Ratones SCID , Datos de Secuencia Molecular , Metástasis de la Neoplasia , Neoplasias/patología , Fragmentos de Péptidos/farmacología , Bazo/patologíaAsunto(s)
Publicaciones Periódicas como Asunto , Sociedades Científicas/historia , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/patología , Enfermedades Cardiovasculares/terapia , Diabetes Mellitus/diagnóstico , Diabetes Mellitus/patología , Diabetes Mellitus/terapia , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Sociedades Científicas/organización & administraciónRESUMEN
In this minireview, we focus on advances in our knowledge of the human erythrocyte proteome and interactome that have occurred since our seminal review on the topic published in 2007. As will be explained, the number of unique proteins has grown from 751 in 2007 to 2289 as of today. We describe how proteomics and interactomics tools have been used to probe critical protein changes in disorders impacting the blood. The primary example used is the work done on sickle cell disease where biomarkers of severity have been identified, protein changes in the erythrocyte membranes identified, pharmacoproteomic impact of hydroxyurea studied and interactomics used to identify erythrocyte protein changes that are predicted to have the greatest impact on protein interaction networks.
Asunto(s)
Anemia de Células Falciformes/metabolismo , Eritrocitos Anormales/metabolismo , Proteoma/metabolismo , Proteómica/métodos , Anemia de Células Falciformes/patología , Eritrocitos Anormales/patología , Humanos , Proteómica/tendenciasRESUMEN
The challenges of identifying and controlling emerging diseases impact individual health, as well as political, social and economic situations. In this review we discuss the role of proteomics for investigation of pathogen discovery, outbreak investigation, bio-defense, disease control, host-pathogen dynamics and vaccine development of emerging and neglected tropical diseases (NTDs). In the future the discipline of proteomics may help define multiple aspects of emerging and NTDs with respect to personalized medicine and public health.